ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:2000480;negative regulation of cAMP-dependent protein kinase activity;12.0;1.0;0.9481203125901445;9.628524252492122;1429.0529900327056;7.697632086000634;0.04782911751220199;0.8417775754447168;[PKIG]
GO:0016925;protein sumoylation;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;311.84626772129184;6.250713103064308;0.010437213937211602;0.7159023839588838;[CBX4, BCL11A]
GO:0046854;phosphatidylinositol phosphorylation;8.0;1.0;0.875;9.628524252492122;218.7418113453505;5.049685808968129;0.007321091570879569;0.6332411671050352;[FGF5, CD19]
GO:0022008;neurogenesis;4.0;0.8653626801206646;0.6826813400603323;9.292052015870908;21.066225782797595;5.572381008289503;7.050676185779127E-4;0.5349718239061428;[CDH1, NUP133, BCL11A, CIT]
GO:0002237;response to molecule of bacterial origin;4.0;0.6873818243518346;0.5936909121759173;8.741221057491218;31.746667436368902;4.018171853803189;0.0010625323889495053;0.45548949546759565;[MEF2C, ABCB4, CD24, NR1H2, CD180, STAP1, FCGR2B]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[AKT1, ACTN4, CLDN3, ABCB4, TGFB1, CD24]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[EHMT2, MEF2C, PKIG, EZH2, PAWR, PAX5, AES, MMP12, FLNA, NR1H2, GMNN, TLE4, CIITA, HHEX, RFC1, E2F7, KLF8, BCL11A, IFNA2, PTPRK, XPO1, ARID4A, TGFB1, CBX4, HMGA1, MEIS2]
GO:0051000;positive regulation of nitric-oxide synthase activity;7.0;1.0;0.8509193652572005;9.628524252492122;123.23454311126406;6.832634648514029;0.0041245492540456985;0.7003406189322132;[FCER2, AKT1]
GO:0006958;complement activation, classical pathway;8.0;1.0;0.875;9.628524252492122;171.02669507306572;4.7081694254602375;0.005724109570062889;0.6157760033703056;[, IGHM, CR2, IGHG1, IGKC, IGLV1-44, IGHD, IGHA1, IGKV3-20]
GO:0050716;positive regulation of interleukin-1 secretion;10.0;0.8933024483968273;0.861892236059334;9.567899630675686;755.7001440922696;6.409777797693995;0.0252926037367935;0.7430373465201421;[IGHD]
GO:0070207;protein homotrimerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;6.444869117505266;0.002859955186148837;0.6805102716434839;[TCL1A]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[HLA-DOA, HLA-DOB, AP2M1, DNM2, HLA-DQA1, FCGR2B]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[AKT1, MEF2C, SFN, ARHGAP6, PKN1, BLK, E2F7, SH2B1, BTK, CD24, SPTAN1, PCNA, GNAI2, CELSR1, EPS8L1, STMN1, CIT, FGF5, LHCGR, MAP2K2, DGKZ, NRBP1, MELK, CNOT3, PPP2R1A, PRL, RALGPS2, MAP4K1, RHOG, CXCR5, SIPA1, TSC2, TGFB1, BLNK]
GO:0033138;positive regulation of peptidyl-serine phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;5.152100814396198;0.026061291479152104;0.6787196871063318;[IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, TCL1A, AKT1, IFNA14, IFNA16, IFNA10, IFNA21, TGFB1]
GO:0032600;chemokine receptor transport out of membrane raft;11.0;1.0;0.9324289523296623;9.628524252492122;247.9928586842006;9.777073627680469;0.008300097801077391;0.9324289523296623;[CD24]
GO:0042308;negative regulation of protein import into nucleus;9.0;0.9326813400603323;0.8625812952104552;9.592156608321247;779.1118030345037;7.138016298065211;0.026076170892464952;0.7612791106150483;[PKIG]
GO:0007264;small GTPase mediated signal transduction;6.0;0.7369933605727446;0.6916169928765168;8.741221057491218;26.42836680105094;4.015022244900292;8.845336528452411E-4;0.5284487369119741;[CELSR1, ARHGAP6, RALGPS2, RHOG, EPS8L1]
GO:2000251;positive regulation of actin cytoskeleton reorganization;9.0;1.0;0.896240625180289;9.628524252492122;130.7363647434596;6.8867018697843045;0.004375628472874139;0.7484268790654467;[STAP1]
GO:0065004;protein-DNA complex assembly;6.0;0.6547035408479693;0.6504720830141292;8.32924126836186;63.417908820271286;4.458953633836253;0.0021225403358019965;0.55115140878708;[CCNH, GMNN, H1FX, NASP, TCF4, BRD2, MCM2, HIST1H2BK, GTF2H1, RAD51]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[TCL1A, CLDN3, CD79B, CD79A, NUP54, RAD51]
GO:0007268;chemical synaptic transmission;7.0;0.7369933605727446;0.7194160455435727;8.663443356448536;23.173347188538074;3.922001705478042;7.755910757418987E-4;0.5514907148670789;[PNOC]
GO:1903413;cellular response to bile acid;6.0;1.0;0.8231203125901445;9.628524252492122;286.3546574774815;8.67846133901236;0.009584032683311037;0.7669372290569613;[ABCB4]
GO:0006974;cellular response to DNA damage stimulus;4.0;0.5696777571895439;0.534838878594772;7.469040003138749;28.997869804256865;3.161008442547652;9.705326059599744E-4;0.4116541187538124;[AKT1, SFN, UNG, GTF2H1, MACROD2, CNOT3, RFC1, SMC1A, E2F7, RAD51, CCNH, PCNA, DCLRE1A, HMGA1, POLE2]
GO:0009967;positive regulation of signal transduction;6.0;0.44130843764162375;0.5437745314109563;6.712834686611667;140.23187634019237;2.4492930892588385;0.004693434700611163;0.44837727507861835;[, AKT1, SFN, JUP, GPR18, EZH2, ARHGAP6, MMP12, FLNA, BIK, PKN1, HHEX, ADAMTS20, SH2B1, FCGR2B, ACTN4, CD19, CD24, BANK1, GNAI2, PPP1CA, NUP62, SEH1L, FCRL2, FCRL3, FGF5, CDH3, MAP2K2, CD180, CCDC22, P2RX5, PPP2R1A, SKP2, POR, IFNA2, PRL, MAP4K1, STAP1, TGFB1, BLNK]
GO:1900028;negative regulation of ruffle assembly;9.0;1.0;0.896240625180289;9.628524252492122;173.84791521056468;8.16763571524637;0.005818533269131697;0.8139338954918922;[STAP1]
GO:1903416;response to glycoside;4.0;0.7866048967936545;0.6433024483968273;8.840066892127851;27.321196622860832;8.16763571524637;9.144158634865458E-4;0.6676932703116032;[ABCB4]
GO:0051770;positive regulation of nitric-oxide synthase biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;147.28763043943843;7.069023426578259;0.0049295844405465;0.7124295520356204;[FCER2]
GO:0002768;immune response-regulating cell surface receptor signaling pathway;6.0;0.6835726970475526;0.6649066611139208;8.807543700422292;76.39633531366081;3.743987405881668;0.0025569165907102184;0.5145880026401528;[, MEF2C, BTK, CD79B, CD79A, CD19, IGHA1, HLA-DQA1, CD24, IGHM, IGHD, IGKC, IGHG1, BLK, IGLV1-44, IGKV3-20, CR2, FCGR2B]
GO:2000768;positive regulation of nephron tubule epithelial cell differentiation;8.0;1.0;0.875;9.628524252492122;415.05780765516636;8.67846133901236;0.013891611294443005;0.8188169164668168;[CD24]
GO:0002925;positive regulation of humoral immune response mediated by circulating immunoglobulin;10.0;0.8933024483968273;0.861892236059334;9.592156608321247;508.6670988930833;8.390779266560578;0.01702463002928348;0.8443458537639685;[FCER2]
GO:0033762;response to glucagon;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;74.03337757263446;6.166155715036245;0.0024778305216419678;0.6662568552797195;[ABCB4]
GO:0001959;regulation of cytokine-mediated signaling pathway;6.0;0.6108066114563391;0.628523618318314;8.112176763124033;55.1119710577094;4.759793790865545;0.0018445480737477274;0.5665363884080561;[STAP1, CD24, MMP12, NR1H2]
GO:0034614;cellular response to reactive oxygen species;5.0;0.7671156992804218;0.6737988615011312;9.197741336399668;144.094088465717;5.076593261888053;0.004822699464687224;0.5498582273596049;[PTPRK, AKT1, DNM2, BTK, PCNA, EZH2]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[FGF5, CD19, TGFB1]
GO:0051898;negative regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.79440420981607;6.063501560976162;0.00799223380789131;0.6850877518099798;[TSC2, BANK1, AKT1]
GO:0043406;positive regulation of MAP kinase activity;12.0;0.7043150770688792;0.8002778511245842;9.369013057007038;2605.6877929993507;4.201124524534153;0.08721002546492271;0.6629660161470909;[, MAP2K2, TGFB1, CD24, EZH2, MAP4K1, PKN1]
GO:0035023;regulation of Rho protein signal transduction;9.0;0.8436909121759173;0.8180860812682478;9.318369324188282;48.758993290020136;4.879233827729558;0.0016319196251719597;0.645764870037956;[STMN1, PLEKHG1, EPS8L1, GPR18]
GO:0045947;negative regulation of translational initiation;9.0;0.7508913569872202;0.7716863036738992;9.377209824211215;1335.4538949630598;6.832634648514029;0.044696440033937586;0.7456618788553018;[BANK1]
GO:1904478;regulation of intestinal absorption;6.0;0.7671156992804218;0.7066781622303554;9.223059144383958;30.838810196503868;7.57984905034425;0.0010321472241496931;0.710754145523778;[ABCB4]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[AKT1, MEF2C, CLDN7, CDC6, FCRL3, MMP12, EPCAM, FLNA, FGF5, CDH3, CORO1A, TCL1A, SKP2, CD24, PRL, RHOG, GNAI2, LTBP3, TGFB1, LAMC2, MEIS2]
GO:0045786;negative regulation of cell cycle;5.0;0.5089359064165209;0.5447089650691808;7.0970975870692286;42.34575940812408;3.5270983854209863;0.0014172744586806725;0.47061698731819834;[EHMT2, FBXO5, SFN, CDC6, EZH2, PTPRK, PCNA, SIPA1, GMNN, KNTC1, TGFB1, CNOT3, HHEX, SMC1A, E2F7, WEE1, RAD51]
GO:0038095;Fc-epsilon receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.989581884898423;0.002626513627734276;0.6301674496329921;[BTK, IGKC, IGLV1-44, IGKV3-20]
GO:0060548;negative regulation of cell death;5.0;0.5408746917014966;0.5606783577116685;7.270369308343265;41.94029430001592;2.875336421023895;0.0014037039064071987;0.4372858501489002;[AKT1, MEF2C, CLDN7, ABCB4, SFN, UNG, FLNA, CORO1A, ADAMTS20, TCL1A, POR, GNAI2, CBX4, NUP62]
GO:0045666;positive regulation of neuron differentiation;8.0;0.6181399273706679;0.684069963685334;8.712233520617966;337.32148776029015;3.9481280100702625;0.011289846625707336;0.576907450041722;[CPNE5, MEF2C, TCF4, EZH2]
GO:0007595;lactation;6.0;1.0;0.8231203125901445;9.628524252492122;25.956233089099676;5.9928839937622085;8.687317623989867E-4;0.6295966787287501;[ABCB4, PRL]
GO:0097193;intrinsic apoptotic signaling pathway;6.0;0.7436939687323844;0.6949672969563367;9.0689084645567;50.98493142520191;4.74012102526684;0.0017064197713422317;0.5655303222604612;[MELK, SFN, CD24]
GO:0042278;purine nucleoside metabolic process;7.0;0.5846489169746516;0.6432438237445264;8.60267131810644;265.01900288978453;5.433268205826786;0.008869947525103323;0.6287769539759931;[MACROD2, RAN]
GO:0038096;Fc-gamma receptor signaling pathway involved in phagocytosis;10.0;1.0;0.9152410118609203;9.628524252492122;384.64074149301706;4.886724499458715;0.01287357946357817;0.6651483300191682;[IGHG1, IGKC, IGLV1-44, FCGR2B, IGKV3-20]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, SPIB, AKT1, MEF2C, JUP, PAX5, MMP12, EPCAM, NR1H2, ATAD2, GTF2H1, CIITA, HHEX, E2F5, E2F7, POU2AF1, CCNH, EBF1, PRL, ARID4A, TGFB1, HMGA1, TCF4, MEIS2]
GO:0001890;placenta development;4.0;1.0;0.75;9.628524252492122;49.86610466882393;6.193554689224359;0.0016689736466849693;0.5667386748366816;[ABCB4, E2F7]
GO:0050850;positive regulation of calcium-mediated signaling;8.0;0.7763722522362496;0.7631861261181248;9.283683766200392;239.92176968958296;6.039404009397101;0.008029965715936047;0.6838554019015759;[P2RX5]
GO:0010918;positive regulation of mitochondrial membrane potential;5.0;1.0;0.7902410118609202;9.628524252492122;24.658349685322438;7.57984905034425;8.252927728937918E-4;0.6778748447945537;[TCL1A, AKT1]
GO:0071392;cellular response to estradiol stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;338.1710882258028;6.221725566191056;0.011318281988697268;0.6412996473849828;[ABCB4]
GO:0097068;response to thyroxine;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;148.64568421023415;8.16763571524637;0.004975037278085989;0.7408135829017477;[ABCB4]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[AKT1, HLA-DQA1, FCER2, ALOX5, IGHG1, IFNA14, IFNA16, IFNA10, IFNA21, CIITA, IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, CXCR5, TGFB1]
GO:0032782;bile acid secretion;9.0;1.0;0.896240625180289;9.628524252492122;69.42950734212523;8.16763571524637;0.002323743128241031;0.8139338954918922;[ABCB4]
GO:0071312;cellular response to alkaloid;6.0;0.7866048967936545;0.7164227609869718;9.245532000236016;164.36700762083373;6.280566066213989;0.005501215824366272;0.6443087532925187;[ABCB4, RAD51]
GO:0032024;positive regulation of insulin secretion;10.0;0.9326813400603323;0.8815816818910864;9.59953671561887;1037.3763533530775;5.514393750639154;0.03472005296862251;0.6972473647141411;[BLK]
GO:0050855;regulation of B cell receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;68.86251036091213;6.686031174322154;0.0023047662495439825;0.692843310444282;[BLK, FCRL3, PAX5, STAP1]
GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation;10.0;0.7866048967936545;0.8085434602577476;9.446202695698167;779.3603785568229;4.60092389510664;0.02608449049149353;0.6505324738215158;[IFNA2, BANK1, STAP1, TGFB1, CD24]
GO:0050853;B cell receptor signaling pathway;10.0;0.9326813400603323;0.8815816818910864;9.582004236857228;219.43154282413207;4.948759890378168;0.007344176262756358;0.6683208227957298;[, BLK, IGHM, CD79B, CD79A, IGHG1, IGKC, CD19, IGHA1, MEF2C, BTK, IGHD]
GO:0031295;T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;354.8971974647038;5.845247994956144;0.011878089812402261;0.6951668794741764;[BTLA, AKT1, CD24]
GO:0033198;response to ATP;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;115.93137747960115;6.375876246018314;0.0038801188727762915;0.6491829203200885;[P2RX5]
GO:1900165;negative regulation of interleukin-6 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;618.5369298683007;7.8311634786251565;0.020701874395595732;0.8157270763441555;[BANK1]
GO:0048701;embryonic cranial skeleton morphogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;46.18089108149027;6.280566066213989;0.0015456328643938164;0.6443087532925187;[PAX5]
GO:0038083;peptidyl-tyrosine autophosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;522.6399477532146;5.905872616772578;0.017492288705884526;0.7172676121338334;[BLK, BTK]
GO:1902227;negative regulation of macrophage colony-stimulating factor signaling pathway;8.0;1.0;0.875;9.628524252492122;445.66462392255374;9.083926447120524;0.014915993890566151;0.839552420951524;[STAP1]
GO:0043410;positive regulation of MAPK cascade;10.0;0.6634067003016617;0.7469443620117512;9.174268980214526;1017.2390743488962;3.4929394666096676;0.03404607636272706;0.5938700986216354;[, CD24, EZH2, MAP4K1, FCRL3, BANK1, GNAI2, PKN1, MAP2K2, TGFB1, FCGR2B]
GO:0051281;positive regulation of release of sequestered calcium ion into cytosol;13.0;0.8933024483968273;0.9092061889660501;9.585964638073326;905.0686146861244;6.139487467954083;0.03029183202467376;0.7765286393941734;[CD19]
GO:0042326;negative regulation of phosphorylation;8.0;0.579397892394798;0.664698946197399;8.17769137023466;181.49265030324682;3.6545808181660835;0.00607439567286886;0.5618954329964018;[PPP2R1A, AKT1, SFN, PKIG, PKN1, TSC2, STAP1, TGFB1, HHEX, NUP62]
GO:0002587;negative regulation of antigen processing and presentation of peptide antigen via MHC class II;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;144.69507589410327;9.083926447120524;0.004842813973061743;0.8154717862087246;[HLA-DOA, HLA-DOB]
GO:0050861;positive regulation of B cell receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;365.0896954818653;7.8311634786251565;0.01221922354838398;0.7754860644832351;[STAP1]
GO:0072112;glomerular visceral epithelial cell differentiation;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;72.77032193269073;7.8311634786251565;0.002435557186049328;0.7514054297404357;[CD24]
GO:0050869;negative regulation of B cell activation;8.0;0.7586651285174919;0.754332564258746;9.158520623246385;160.49678057359853;6.375876246018314;0.005371682808073518;0.701062607729944;[PAWR, BANK1, BTK, PKN1, FCGR2B]
GO:0019731;antibacterial humoral response;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;115.72816977122699;6.221725566191056;0.0038733176936520722;0.6690987000520388;[IGHM, HIST1H2BK, IGHA1, IGKV3-20]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[VPREB3, CORO1A, NUP85, IGLV1-44, IGHA1, TGFB1, IGKV3-20, IGHM, CXCR5, IGKC, EPCAM]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[MEF2C, CD180, ABCB4, STAP1, NR1H2]
GO:0032376;positive regulation of cholesterol transport;8.0;0.811012628672052;0.780506314336026;9.32314260294094;149.26567110214077;6.7325511899570465;0.004995787681406127;0.719302980950052;[NR1H2, ABCB4]
GO:0033189;response to vitamin A;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;42.3983228833862;6.781341354126479;0.0014190337108936392;0.6977174774718518;[ABCB4]
GO:0030595;leukocyte chemotaxis;6.0;0.6873818243518346;0.6668112247660618;8.768322987269011;62.06300720445581;4.857092701852345;0.002077192998052941;0.5715122592407831;[CXCR5, CORO1A, NUP85]
GO:0010524;positive regulation of calcium ion transport into cytosol;12.0;0.811012628672052;0.8536266269261705;9.4949928598676;446.85811756486936;5.825829909099042;0.01495593904869991;0.7460535250702665;[CD19, P2RX5]
GO:0051712;positive regulation of killing of cells of other organism;5.0;0.7192862368539868;0.6498841302879137;9.05316010758856;72.11799800547139;7.292166977892469;0.0024137244912587163;0.6631627702307852;[FCER2]
GO:0071549;cellular response to dexamethasone stimulus;9.0;1.0;0.896240625180289;9.628524252492122;704.2721689024621;6.343086423195323;0.023571355689363423;0.7206263598461826;[TGFB1, ABCB4]
GO:0010760;negative regulation of macrophage chemotaxis;10.0;1.0;0.9152410118609203;9.628524252492122;861.5414298964416;7.9853141584524145;0.02883501632168613;0.8236103492792612;[STAP1]
GO:0034394;protein localization to cell surface;5.0;1.0;0.7902410118609202;9.628524252492122;29.829169826127035;6.686031174322154;9.983554695705216E-4;0.6321649570480018;[FLNA, PTPRK]
GO:1903169;regulation of calcium ion transmembrane transport;8.0;0.6260725219892441;0.688036260994622;8.50005900067433;58.212370637888874;4.835431205071165;0.001948315657517866;0.6222841766978864;[CORO1A, CD19, TGFB1, TSPAN13]
GO:0061098;positive regulation of protein tyrosine kinase activity;11.0;0.8436909121759173;0.8542744084176208;9.55953138100517;2154.6219316186807;5.8650506222523235;0.07211325701743153;0.7323679139043926;[STAP1, CD24]
GO:0007179;transforming growth factor beta receptor signaling pathway;8.0;0.7586651285174919;0.754332564258746;9.05316010758856;29.903672154863813;5.2552850506314295;0.0010008489954655988;0.6437555218850388;[PTPRK, TGFB1, ZYX]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[EHF, CCNH, SPIB, MEF2C, PAX5, FLNA, GTF2H1, ARID4A, HMGA1, MEIS2, POU2AF1]
GO:0006367;transcription initiation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;4.629579150867016;0.015969835568764485;0.6329975182530758;[CCNH, NR3C2, NRBP1, MAZ, TCF4, NR1H2, GTF2H1]
GO:0050871;positive regulation of B cell activation;8.0;0.7436939687323844;0.7468469843661922;9.117698628726131;160.32529438548238;4.695669262696007;0.00536594331968482;0.6151367444652258;[, IGHM, IGHG1, MEF2C, FCRL3, BTK, IGHD, UNG, IGKC, IGHA1, TGFB1]
GO:0051289;protein homotetramerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;5.433268205826786;0.002859955186148837;0.6287769539759931;[CD79A]
GO:0035914;skeletal muscle cell differentiation;4.0;0.8653626801206646;0.6826813400603323;9.292052015870908;21.066225782797595;5.845247994956144;7.050676185779127E-4;0.5489262542938873;[MEF2C, PAX5]
GO:0043031;negative regulation of macrophage activation;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;126.92306413003195;7.57984905034425;0.00424800073309046;0.738553198190834;[FCGR2B, CD200]
GO:0045332;phospholipid translocation;8.0;1.0;0.875;9.628524252492122;116.86638763413639;6.641579411751319;0.003911412821194078;0.7146506799819907;[ABCB4]
GO:1990963;establishment of blood-retinal barrier;4.0;1.0;0.75;9.628524252492122;32.15320660831846;9.777073627680469;0.001076138889173156;0.75;[ABCB4]
GO:0098655;cation transmembrane transport;6.0;0.518007056267642;0.5821238407239655;7.133254815668575;43.36096628843346;3.3345334612122706;0.0014512525193377528;0.4936485088682041;[DENND5B, ATP2A3, P2RX5]
GO:0016055;Wnt signaling pathway;7.0;0.5916390046238794;0.6467388675691402;7.647522783625538;28.581916314885376;4.0633408221711;9.566110170045473E-4;0.558718803867703;[CELSR1, CDH3, AP2M1, TLE4, PFN1, CD24, CDK14, HHEX, AES]
GO:0051725;protein de-ADP-ribosylation;7.0;1.0;0.8509193652572005;9.628524252492122;151.15475272427284;8.390779266560578;0.005059013543235805;0.7800242071602487;[MACROD2]
GO:0032485;regulation of Ral protein signal transduction;9.0;1.0;0.896240625180289;9.628524252492122;48.758993290020136;8.67846133901236;0.0016319196251719597;0.8400575416471059;[RALGPS2]
GO:0048041;focal adhesion assembly;8.0;1.0;0.875;9.628524252492122;92.53238439646684;6.599019797332524;0.0030969756320103773;0.712474179321389;[PTPRK, ARHGAP6]
GO:0019722;calcium-mediated signaling;7.0;0.7192862368539868;0.710562483684194;8.712233520617966;27.814661162170232;4.835431205071165;9.309316775279788E-4;0.598203541955087;[BTK, CXCR5]
GO:0035116;embryonic hindlimb morphogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;58.806290969860136;6.444869117505266;0.001968193636535348;0.6527112189764278;[AFF3]
GO:0071217;cellular response to external biotic stimulus;4.0;1.0;0.75;9.628524252492122;54.03966511499906;9.777073627680469;0.001808658958857907;0.75;[ABCB4]
GO:1905233;response to codeine;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;91.95678064542024;9.777073627680469;0.0030777106924725914;0.8509193652572005;[ABCB4]
GO:1905232;cellular response to L-glutamate;7.0;1.0;0.8509193652572005;9.628524252492122;543.0623632319648;8.390779266560578;0.01817580857297763;0.7800242071602487;[ABCB4]
GO:1905231;cellular response to borneol;6.0;1.0;0.8231203125901445;9.628524252492122;82.1226699471212;9.777073627680469;0.0027485718575255523;0.8231203125901445;[ABCB4]
GO:0030183;B cell differentiation;6.0;0.7307253602413294;0.6884829927108091;9.022388448921806;64.35544597283358;5.2552850506314295;0.0021539188605695985;0.5918758344751833;[IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, HHEX, BLNK, TPD52, CR2, IFNA14, IFNA16, IFNA10, CD79B, CD79A, IFNA21, FCGR2B]
GO:1905237;response to cyclosporin A;6.0;0.9326813400603323;0.7894609826203107;9.533214072687796;72.72722829191152;9.777073627680469;0.002434114880674206;0.8231203125901445;[ABCB4]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[AKT1, PNOC, GPR18, RHOG, CXCR5, GNAI2, FLNA, CELSR1, LHCGR, DGKZ, GNB2]
GO:0035590;purinergic nucleotide receptor signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;27.195621953761602;6.641579411751319;9.102129923216596E-4;0.6905700452391912;[P2RX5]
GO:1905235;response to quercetin;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;83.8240692754011;9.777073627680469;0.0028055161618830964;0.7902410118609202;[ABCB4]
GO:0042100;B cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.387362195675234;50.60132884827668;6.166155715036245;0.00169358093831245;0.6384578026126634;[IFNA5, IFNA4, IFNA7, MEF2C, CR2, IFNA14, IFNA16, IFNA2, CD180, IFNA8, CD79A, MS4A1, IFNA21, IFNA10]
GO:0043278;response to morphine;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;93.3430750065417;6.280566066213989;0.0031241087171554015;0.6721078059595746;[ABCB4]
GO:0042742;defense response to bacterium;6.0;0.7866048967936545;0.7164227609869718;9.193206181234276;69.6526388451159;4.021331414093558;0.0023312111388408135;0.5287713881179241;[, IGHG1, SEH1L, IGHA1, IGKV3-20, IGHM, IGHD, HIST1H2BK, IGKC]
GO:1901557;response to fenofibrate;5.0;1.0;0.7902410118609202;9.628524252492122;104.6800071720804;9.777073627680469;0.00350354563415944;0.7902410118609202;[ABCB4]
GO:0042104;positive regulation of activated T cell proliferation;10.0;1.0;0.9152410118609203;9.628524252492122;649.8896198547563;6.599019797332524;0.021751220713853325;0.7527151911823093;[CD24]
GO:0006898;receptor-mediated endocytosis;6.0;0.6799073451904818;0.6630739851853854;8.48339194818912;28.437470009997963;4.178651668682095;9.517765291732001E-4;0.536816753253722;[AP2M1, IGLV1-44, IGHA1, IGKV3-20, DNM2, IGKC, FCGR2B]
GO:0032913;negative regulation of transforming growth factor beta3 production;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;85.63944001314535;9.777073627680469;0.002866274986747803;0.8509193652572005;[CD24]
GO:0009914;hormone transport;4.0;0.5756379274792419;0.5378189637396209;7.480089839325334;21.707737847050485;5.358233019883872;7.265384500450821E-4;0.524020285820179;[ABCB4, BTK]
GO:0007218;neuropeptide signaling pathway;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;26.976932752798508;5.123113277522946;9.028936615729279E-4;0.5851165638517994;[PNOC]
GO:0007219;Notch signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.50247477320489;4.99795013456894;8.87013979980389E-4;0.5787157149004503;[HHEX, FCER2, TGFB1, KRT19]
GO:0051573;negative regulation of histone H3-K9 methylation;11.0;0.8933024483968273;0.8790801765280758;9.571365838652174;805.1350321075869;7.57984905034425;0.026947144950155395;0.8200627852632958;[PAX5]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[SPIB, AKT1, MEF2C, JUP, MMP12, ATAD2, CIITA, HHEX, E2F5, E2F7, POU2AF1, CCNH, HMGA1, TCF4, NUP62, RAN, EHF, NUP85, PAWR, PAX5, EPCAM, NR1H2, GTF2H1, CDH3, CDH1, MAP2K2, RFC1, EBF1, IFNA2, PRL, RHOG, ARID4A, HGS, STAP1, TGFB1, DNM2, MEIS2]
GO:0061092;positive regulation of phospholipid translocation;9.0;1.0;0.896240625180289;9.628524252492122;348.31453857334856;8.67846133901236;0.011657774143316984;0.8400575416471059;[ABCB4]
GO:0032597;B cell receptor transport into membrane raft;11.0;0.9326813400603323;0.8987696223598284;9.59462270081644;336.41565742558566;9.777073627680469;0.011259529299599152;0.9324289523296623;[CD24]
GO:0072139;glomerular parietal epithelial cell differentiation;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;51.0109489693332;9.083926447120524;0.0017072905551300363;0.8154717862087246;[CD24]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[FGF5, MEF2C, IFNA14, IFNA16, IFNA10, IFNA21, TGFB1, PNOC, IFNA5, IFNA4, IFNA7, IFNA2, PRL, IFNA8, FCGR2B]
GO:1904140;negative regulation of microglial cell migration;10.0;1.0;0.9152410118609203;9.628524252492122;1064.7186091142864;9.777073627680469;0.035635173662517575;0.9152410118609203;[STAP1]
GO:0030336;negative regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.20713857156096;158.04059951544355;4.3090134865453384;0.00528947663847651;0.5712825153487487;[MEF2C, STAP1, TGFB1, JUP, GPR18, PTPRK]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[AKT1, SKP2, PCNA, KLHL14, UBE2M, HIST1H2BK]
GO:0046718;viral entry into host cell;7.0;0.7671156992804218;0.7344772148974115;8.935377071932177;28.374411874040543;5.346256828837156;9.496660301113433E-4;0.6243271881103005;[ITGB6, CR2]
GO:0060100;positive regulation of phagocytosis, engulfment;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;308.80984280932773;7.57984905034425;0.010335587528013168;0.7838744581139225;[STAP1]
GO:0033280;response to vitamin D;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;74.55580141320215;6.375876246018314;0.002495315577434836;0.6769819729871445;[TGFB1, ABCB4]
GO:1903980;positive regulation of microglial cell activation;8.0;1.0;0.875;9.628524252492122;155.50143499853152;7.697632086000634;0.005204493087195169;0.7686572628545723;[STAP1]
GO:0010839;negative regulation of keratinocyte proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;86.66714155745981;7.212124270218933;0.002900671232564666;0.7197477358342742;[SFN, PTPRK]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[EHMT2, MEF2C, PKIG, EZH2, PAWR, PAX5, AES, MMP12, NR1H2, TLE4, CIITA, HHEX, RFC1, E2F7, KLF8, BCL11A, XPO1, TGFB1, CBX4, MEIS2]
GO:0006855;drug transmembrane transport;5.0;0.5781283279524737;0.5793051758371571;7.293149336675085;29.084245973375534;5.407625775213448;9.73423538606871E-4;0.5667872454856517;[ABCB4]
GO:0050892;intestinal absorption;4.0;0.811012628672052;0.655506314336026;9.176539128749065;23.07461412231494;6.375876246018314;7.722865688694012E-4;0.576062607729944;[ABCB4]
GO:0030449;regulation of complement activation;8.0;0.6873818243518346;0.7186909121759173;9.298282565621545;245.7676390307622;5.076593261888053;0.008225621701844479;0.6346172154986847;[IGHG1, IGKC, CD19, IGLV1-44, CR2, IGKV3-20]
GO:0071475;cellular hyperosmotic salinity response;7.0;0.9326813400603323;0.8172600352873667;9.567899630675686;243.83975882422638;8.390779266560578;0.008161097286311265;0.7800242071602487;[ABCB4]
GO:0034644;cellular response to UV;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;66.19362175939281;5.420364800990877;0.0022154409498949313;0.628117073252615;[PTPRK, PCNA]
GO:0071356;cellular response to tumor necrosis factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;4.973052582947213;0.0027327542132076126;0.5774424529526606;[TCL1A, AKT1]
GO:0071236;cellular response to antibiotic;4.0;0.6369964171292115;0.5684982085646058;7.703233390639544;41.40086873190647;5.085725745451326;0.0013856498180940687;0.5100842511328143;[MEF2C, PCNA, ABCB4, EZH2]
GO:1904151;positive regulation of microglial cell mediated cytotoxicity;6.0;1.0;0.8231203125901445;9.628524252492122;47.821141739261684;9.777073627680469;0.0016005305777796722;0.8231203125901445;[STAP1]
GO:0035335;peptidyl-tyrosine dephosphorylation;8.0;0.8933024483968273;0.8216512241984136;9.52844079393514;179.24922260518233;5.181953777545879;0.005999310166768488;0.6400053571691908;[PTPRK]
GO:2001025;positive regulation of response to drug;5.0;0.6519675769143192;0.6162248003180799;7.963516488903211;42.538124801348104;6.481236761676141;0.0014237127552742665;0.6216917612613706;[ABCB4, PAWR]
GO:0032467;positive regulation of cytokinesis;7.0;0.7043150770688792;0.7030769037916401;9.015419779605713;142.0565341908292;6.193554689224359;0.004754504356786525;0.6676580400938822;[CXCR5, CDC6, CIT, NUP62]
GO:0050776;regulation of immune response;4.0;0.37937792944451876;0.4396889647222594;5.635843344046521;22.446924158408432;2.846578861728843;7.512783506617425E-4;0.39557417536826767;[, MEF2C, IGHA1, HLA-DQA1, FCRL3, PAWR, PAX5, MMP12, FCER2, TLR10, UNG, NR1H2, PKN1, IGHG1, CD180, BLK, IGLV1-44, CR2, FCGR2B, BTK, STXBP2, CD79B, CD79A, CD19, CD24, CD200, IGHM, IFNA2, IGHD, IGKC, STAP1, TGFB1, IGKV3-20]
GO:0036146;cellular response to mycotoxin;5.0;0.8933024483968273;0.736892236059334;9.427853557029971;58.05627655683236;8.16763571524637;0.001943091329100457;0.7079342821725234;[ABCB4]
GO:0050829;defense response to Gram-negative bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.407625775213448;0.0023911797157970473;0.627465598881932;[IGHM, HIST1H2BK]
GO:0032461;positive regulation of protein oligomerization;7.0;0.8653626801206646;0.7836007053175329;9.5544162803384;141.07486917829812;6.599019797332524;0.004721648912258263;0.6883935445785896;[TCL1A, BIK]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[SPIB, MEF2C, EZH2, FLNA, ATAD2, PKN1, CIITA, HHEX, E2F5, E2F7, POU2AF1, CCNH, BTK, HMGA1, AFF3, NUP62, EHF, HOXA9, ZNF367, BRD2, PAWR, PAX5, AES, GTF2H1, TLE4, CNOT3, RFC1, KLF8, EBF1, BCL11A, ARID4A, CBX4, MEIS2]
GO:1903997;positive regulation of non-membrane spanning protein tyrosine kinase activity;12.0;1.0;0.9481203125901445;9.628524252492122;2433.420620421529;7.9853141584524145;0.0814443982291329;0.8564896500084854;[STAP1]
GO:0006355;regulation of transcription, DNA-templated;9.0;0.4043225613388953;0.5984019058497367;6.838723401371219;245.35026186902695;1.5478292109445575;0.008211652463856259;0.4753966830094131;[NUP107, SPIB, AKT1, JUP, PKIG, MMP12, ATAD2, PKN1, GMNN, CIITA, HHEX, E2F5, E2F7, POU2AF1, FBXO5, BTK, PCNA, NR3C2, TCF4, NUP133, NUP85, ZNF367, EPCAM, NR1H2, TLE4, MAP2K2, CCDC22, RFC1, PPP2R1A, IFNA2, PRL, XPO1, MLF2, CBX4, DNM2, EHMT2, MEF2C, EZH2, FLNA, MAZ, CCNH, PTPRK, HMGA1, AFF3, NUP62, NUP35, RAN, EHF, HOXA9, CDC6, BRD2, PAWR, PAX5, AES, GTF2H1, CDH1, CNOT3, KLF8, EBF1, PFN1, SP140, BCL11A, RHOG, ARID4A, TGFB1, MEIS2]
GO:0007169;transmembrane receptor protein tyrosine kinase signaling pathway;7.0;0.579397892394798;0.6406183114545996;7.564831067780425;28.111912685638995;3.5644675319289507;9.408804185094754E-4;0.533206400604739;[STMN1, AKT1, BTK, FGF5, AP2M1, TSC2, BLK, STAP1, TGFB1, BLNK]
GO:0060856;establishment of blood-brain barrier;4.0;0.8933024483968273;0.6966512241984136;9.34084218004034;32.15320660831846;8.390779266560578;0.001076138889173156;0.6791048419030481;[ABCB4, LSR]
GO:0007565;female pregnancy;3.0;1.0;0.6981203125901445;9.628524252492122;32.8060485501291;5.299736813202263;0.0010979889214459554;0.4691490996802742;[PRL, TGFB1, CLDN4, PNOC]
GO:0007166;cell surface receptor signaling pathway;5.0;0.43360584258713153;0.507043933154486;5.906854975555195;23.17027026302992;2.006850423521684;7.75488093814194E-4;0.39287143584790796;[, AKT1, MEF2C, FLNA, AP2M1, IFNA14, IFNA16, IFNA10, BLK, CORO1A, IFNA21, CIITA, ITGB4, HHEX, ITGB6, TSPAN13, FCGR2B, BTK, CD19, CD24, IGHM, PTPRK, CD37, IGHD, GNAI2, IGKC, CELSR1, IGKV3-20, NUP62, STMN1, IGHA1, HLA-DQA1, CDK14, AES, FCER2, ALOX5, ZYX, FGF5, IGHG1, CDH3, TLE4, IGLV1-44, CR2, P2RX5, TLN1, PFN1, CD79B, CD79A, IFNA5, IFNA4, IFNA7, IFNA2, PRL, IFNA8, CXCR5, KRT19, TSC2, STAP1, TGFB1, BLNK]
GO:0043215;daunorubicin transport;7.0;1.0;0.8509193652572005;9.628524252492122;103.949567617783;9.777073627680469;0.0034790984796300266;0.8509193652572005;[ABCB4]
GO:0002430;complement receptor mediated signaling pathway;9.0;0.9326813400603323;0.8625812952104552;9.57973408832269;218.73839564357212;7.212124270218933;0.007320977250414979;0.7650689957573628;[CR2]
GO:0007204;positive regulation of cytosolic calcium ion concentration;11.0;0.6835726970475526;0.7742153008534385;9.097896001429952;290.3013502407617;4.174954806800768;0.00971612493830514;0.645936335304707;[CD19, CD24, GPR18, CXCR5, P2RX5]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[MEF2C, CD180, STAP1, NR1H2]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, BTK, LY9, IGHA1, IFNA5, IFNA4, IGHM, IFNA7, IFNA2, IFNA8, IGHD, TLR10, IGKC, IGHG1, IFNA14, IFNA16, CD180, IFNA10, BLK, CORO1A, IFNA21, TGFB1, CR2, HIST1H2BK]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[AKT1, MEF2C, CLDN7, SFN, UNG, FLNA, CORO1A, ADAMTS20, TCL1A, POR, GNAI2, CBX4, NUP62]
GO:0070098;chemokine-mediated signaling pathway;7.0;0.7307253602413294;0.7162820453778652;8.999915593069748;30.19135422731818;5.459585514144159;0.00101047745553359;0.6301228223472235;[CXCR5]
GO:0006508;proteolysis;5.0;0.5517781253862416;0.5661300745540411;7.338517941704937;47.85814540089318;2.5985281439167696;0.001601769057033345;0.42312986198474045;[, ST14, MMP12, ADAM28, APEH, IGHG1, IGLV1-44, ADAMTS20, SKP2, IGKC, RANBP1, TGFB1, IGKV3-20]
GO:0071902;positive regulation of protein serine/threonine kinase activity;11.0;0.6763753087927167;0.7706166067260205;9.206529842432747;1260.5827351979337;3.9422628906178643;0.04219056969626795;0.6340364598898325;[, CCNH, TCL1A, AKT1, CDC6, CD24, EZH2, MAP4K1, PKN1, MAP2K2, TGFB1]
